RT Journal Article
SR Electronic
A1 Parry, Nicola
T1 Combining Empagliflozin and Linagliptin with Metformin Reduces HbA1c in Patients with T2DM
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 32
SP 11
OP 12
DO 10.1177/155989771432005
UL http://mdc.sagepub.com/content/14/32/11.abstract
AB Combined empagliflozin and linagliptin as add-on therapy to metformin provided enhanced glucose-reducing efficacy when compared with either drug as monotherapy in individuals with type 2 diabetes mellitus, as discussed in this article.